Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - RETAINED EARNINGS
Retained Earnings REGN - Regeneron Pharmaceuticals, Inc.
27.3 B
LAST VALUE
19.88%
2 YEAR CAGR
39.00%
5 YEAR CAGR
76.66%
10 YEAR CAGR